Filter by content type
Filter by year
Vaccinex Announces Activation of Clinical Sites to Enroll Patients in Studies of Pepinemab as Single Agent in Alzheimer’s Disease and in Combination with KEYTRUDA® in Advanced, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
June 8, 2021 - … treatment benefit to patients with non-small cell lung cancer. We are pleased to have now initiated this new … treatment benefit to patients with non-small cell lung cancer. We are pleased to have now initiated this new … treatment benefit to patients with non-small cell lung cancer. We are pleased to have now initiated this new …
Vaccinex Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 17, 2021 - … head and neck cancer Announced publication of results from CLASSICAL-Lung phase 1b/2 clinical trial in non-small cell lung cancer … Announced the publication of results from the CLASSICAL-Lung phase 1b/2 clinical trial in non-small cell …
Vaccinex Announces Publication of Results from CLASSICAL-Lung Phase 1b/2 Clinical Trial in Non-Small Cell Lung Cancer in the Peer-Reviewed Journal Clinical Cancer Research
April 21, 2021 - … Vaccinex Announces Publication of Results from CLASSICAL-Lung Phase 1b/2 Clinical Trial in Non-Small Cell Lung Cancer … Research Vaccinex Announces Publication of Results from CLASSICAL-Lung Phase 1b/2 Clinical Trial in Non-Small Cell …
Vaccinex Reports Third Quarter 2020 Financial Results and Provides Corporate Update
November 13, 2020 - … and loss of brain metabolic activity. Non-Small Cell Lung Cancer (NSCLC). CLASSICAL-Lung C linical T rial . The recently completed CLASSICAL-Lung study evaluated pepinemab in combination with …
Vaccinex, Inc. to Present at the Virtual Investor KOL Roundtable
October 26, 2020 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington's disease. The company is also … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington's disease. The company is also … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington's disease. The company is also …
Vaccinex Reports Second Quarter 2020 Financial Results and Provides Corporate Update
August 14, 2020 - … will be released by early October 2020 . Non-Small Cell Lung Cancer (NSCLC). CLASSICAL-Lung clinical trial . The CLASSICAL-Lung study is evaluating pepinemab in combination …
Top-Line Results of Phase 2 SIGNAL Study in Huntington’s Disease Support Potential for Cognitive Benefit of Pepinemab
September 22, 2020 - … with avelumab checkpoint inhibitor in Non-Small Cell Lung Cancer . A new collaboration with Merck to test the … with currently active clinical trials in Non-Small Cell Lung Cancer , Huntington's and Alzheimer's disease and a … with avelumab checkpoint inhibitor in Non-Small Cell Lung Cancer . A new collaboration with Merck to test the …
Vaccinex Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 14, 2020 - … Earnings Approaching key topline data in non-small cell lung cancer and Huntington's disease Advancing plans to … Accomplishments: Presented updated interim data from the CLASSICAL-Lung Phase 1b/2 study of the company's lead product … . Pepinemab Clinical Updates: Non-Small Cell Lung Cancer - CLASSICAL-Lung Clinical Trial . The company's ongoing …
Vaccinex to Present Updated Results from CLASSICAL-Lung, Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer at the American Society of Clinical Oncology (ASCO) 2020 Annual Meeting
May 13, 2020 - … Vaccinex to Present Updated Results from CLASSICAL-Lung, Phase 1b/2 Study of Pepinemab (VX15/2503) in … Annual Meeting Vaccinex to Present Updated Results from CLASSICAL-Lung, Phase 1b/2 Study of Pepinemab (VX15/2503) in …
Vaccinex Provides Update of Potentially Pivotal SIGNAL Clinical Trial in Huntington’s Disease
July 7, 2020 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington's disease and new trials pending … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington's disease and new trials pending … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington's disease and new trials pending …